Activity Overview
This online, on-demand virtual symposium brings together experts in the use of continuous glucose monitoring (CGM) in the care of patients with diabetes. In this educational program, these experts differentiate between specific CGM devices to help clinicians recommend the most appropriate technology for their patients based on their treatment needs. In addition, the program highlights opportunities to apply CGM data to help patients achieve improved glycemic control and examines emerging ketone-monitoring technology.
Target Audience
This activity is directed toward internal medicine, primary care, and family medicine physicians as well as nurse practitioners, physician assistants, and registered nurses. Other health care providers who care for patients with diabetes are also invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Explain the distinguishing features between currently available continuous glucose monitoring (CGM) systems
- Incorporate CGM into the management of adults with type 2 diabetes (T2D) in the absence or presence of insulin use
- Discuss integrated diabetes technologies to support individualized diabetes management across varying therapeutic intensities.
- Summarize the emerging role of continuous ketone monitoring (CKM) and combined glucose–ketone monitoring (CGKM) systems in preventing diabetic ketoacidosis (DKA) and enhancing safety for patients with diabetes.

Diana Isaacs, PharmD, BCACP, CDCES, BC-ADM, FADCES, FCCP
Director, Education & Training in
Diabetes Technology
Co-Director, Endocrine Disorders in
Pregnancy
Cleveland Clinic Endocrinology and
Metabolism Institute
Cleveland, OH
Disclosures: Advisor Consultant, Fee for Service Recipient: Lilly, Medtronic MiniMed, Tandem; Speakers Bureau: Abbott, Beta Bionics, Cequr, Dexcom, Lilly, Novo Nordisk, Sanofi

Robert H. Eckel, MD
Professor of Medicine Emeritus
University of Colorado Anschutz Medical
Campus
Aurora, CO
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: 89Bio, Amgen, Arrowhead Pharmaceuticals, Ionis Pharmaceuticals, NewAmsterdam Pharma, Novo Nordisk, Precision BioSciences, Regeneron, The Healthy Aging Co., UpToDate

Javier Morales, MD, FACP, FACE
Associate Clinical Professor of
Medicine
Donald and Barbara Zucker School of
Medicine at Hofstra/Northwell
Hempstead, NY
Disclosures: Advisor, Consultant, Fee for Service Recipient: Amgen, Bayer, Boehringer Ingelheim, Novo Nordisk; Speakers Bureau: Amgen, Bayer, Boehringer Ingelheim, Lily, Novo Nordisk
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Additional Disclaimers
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
This accredited activity has been developed in accordance with applicable accreditation standards to ensure balance, independence, objectivity, and scientific rigor. Faculty were instructed to use generic names where possible and to base recommendations on the best available evidence.
In the context of clinical discussion, proprietary product names may be mentioned. Such references are made for educational purposes only and do not constitute endorsement of any commercial product or service.
Learners are encouraged to independently evaluate the information presented and apply their own clinical judgment when considering patient care decisions.

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here